SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-071737
Filing Date
2024-06-14
Accepted
2024-06-14 16:02:10
Documents
5
Effectiveness Date
2024-06-14

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2417017d1_s8.htm S-8 46784
2 EXHIBIT 5.1 tm2417017d1_ex5-1.htm EX-5.1 7172
3 EXHIBIT 23.1 tm2417017d1_ex23-1.htm EX-23.1 2100
4 EX-FILING FEES tm2417017d1_ex-filingfees.htm EX-FILING FEES 12086
5 GRAPHIC tm2417017d1_ex5-1iimg001.jpg GRAPHIC 16292
  Complete submission text file 0001104659-24-071737.txt   92022
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280207 | Film No.: 241044611
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)